Skip to main content
. 2019 May 13;7:14. doi: 10.1038/s41413-019-0054-y

Fig. 7.

Fig. 7

Osteoclast-specific depletion of HIF-2α increases bone mass. a Osteoclast-specific depletion of HIF-2α in Hif-2αfl/fl and Hif-2αfl/fl;Ctsk-Cre mice was determined by immunohistochemistry with anti-HIF-2α antibody (n = 3; scale bar: 10 μm). b, c Analysis of femoral trabecular bones from 4-month-old Hif-2αfl/fl and Hif-2αfl/fl;Ctsk-Cre mice. Quantitative µCT analysis of trabecular bones (n = 8; b), H&E and TRAP staining and bone histomorphometric analysis (n = 8; c). Scale bar: 100 μm. d, e Quantitative µCT analysis (n = 8; d) and measurement of serum OCN and CTX-1 concentrations (n = 6; e) in OVX or sham-operated Hif-2αfl/fl and Hif-2αfl/fl;Ctsk-Cre mice. f Schematic diagram depicting HIF-2α regulation of bone remodeling. Values are presented as the mean ± SEM (*P < 0.05, **P < 0.01, ***P < 0.005; ‘NS’ not significant). Scale bar: 100 μm. The effects of OVX and osteoclast-specific depletion of Hif-2α (cKO) as well as their interaction in mice were analyzed by two-way ANOVA (d BV/TV: interaction = 0.001 8, OVX < 0.000 1, cKO < 0.000 1; e OCN: interaction = 0.743 6, OVX < 0.000 1, cKO = 0.557 7; e CTX-1: interaction = 0.045 0, OVX < 0.000 1, cKO = 0.002 5)